1
|
Wilson P, O'Connor T, Boland F, Budri A, Moore Z, Phelan N, Patton D. The utility of skin surface temperature measurement in the prediction of diabetic foot ulceration. J Tissue Viability 2025; 34:100851. [PMID: 39965369 DOI: 10.1016/j.jtv.2024.100851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2024] [Revised: 11/12/2024] [Accepted: 12/18/2024] [Indexed: 02/20/2025]
Abstract
AIM Temperature is a marker of inflammation. Research has shown that by measuring skin surface temperature in those with a history of diabetic foot ulceration (DFU), tissue damage can be identified early and reduce rates of subsequent DFU. This study considered whether measuring skin surface temperature using infra-red thermometry can identify early tissue damage and inform clinical practice in a general population with Diabetes Mellitus (DM). METHOD The data presented was taken from a prospective observational study of risk factors in patients with Diabetes. As part of this study, temperature measurements using the Flir E6 Infra-red camera were taken from 216 individuals attending outpatient diabetes clinics in a large urban teaching hospital in Ireland as part of a comprehensive diabetic foot assessment. Measurements were taken at foot sites associated with increased risk at baseline received repeat temperature measurement on 2 subsequent occasions in the following week. Any ulceration was subsequently recorded. RESULTS Discussion: Of the 216 participants, 4 % (n = 9) developed visual ulceration within 7 days. All of these had been identified at high risk at baseline assessment and had a history of foot disease. A temperature differential of ≥2.2 °C between sites of interest was recorded. Temperature ranges varied from 29.1 °C to 37.6 °C. High temperature was considered if over 35 °C. Of those who developed a diabetic foot ulceration within the 7 day follow up period, 78 % (n = 7) had a high temperature. The remaining 22 % (n = 2) who developed ulceration had a temperature reading in the normal range. CONCLUSION Elevated skin surface temperature was seen prior to the development of DFU in all cases in this study. Initial analysis suggests that neither the 35 °C threshold nor a 2.2 °C temperature difference is indicative of inevitable tissue damage in this population due to the high number of false positives seen.
Collapse
Affiliation(s)
- Pauline Wilson
- St James's Hospital, Dublin, Ireland; Royal College of Physicians and Surgeons of Ireland, Ireland.
| | - Tom O'Connor
- Royal College of Physicians and Surgeons of Ireland, Ireland
| | - Fiona Boland
- Royal College of Physicians and Surgeons of Ireland, Ireland
| | - Aglecia Budri
- Royal College of Physicians and Surgeons of Ireland, Ireland
| | - Zena Moore
- Royal College of Physicians and Surgeons of Ireland, Ireland
| | | | - Declan Patton
- Royal College of Physicians and Surgeons of Ireland, Ireland
| |
Collapse
|
2
|
Billings J, Gee J, Ghulam Z, Abdullah HA. Smart Compression Sock for Early Detection of Diabetic Foot Ulcers. SENSORS (BASEL, SWITZERLAND) 2024; 24:6928. [PMID: 39517824 PMCID: PMC11548053 DOI: 10.3390/s24216928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/18/2024] [Revised: 10/09/2024] [Accepted: 10/21/2024] [Indexed: 11/16/2024]
Abstract
The prevention of diabetic foot ulcers remains a critical challenge. This study evaluates a smart compression sock designed to address this issue by integrating temperature, plantar pressure, and blood oxygen sensors and monitoring data recorded by these sensors. The smart sock, developed with input from a certified Pedorthist, was tested on 20 healthy adult participants aged 16 to 53. It includes four temperature sensors and pressure sensors at common ulcer sites (first and fifth metatarsal heads, calcaneus, and hallux), and a blood oxygen sensor on the hallux. The sensors are monitored, and their transduced data are collected and stored through an app installed on a personal cell phone. The mobile app interface is user-friendly, providing intuitive navigation and easy access to the sensors' data. Using repeated measures ANOVA and post hoc tests, we analyzed the impact of various physical activities on physiological changes in the foot. The device effectively detected significant variations in blood oxygen, temperature, and pressure across six activities. Statistical analyses revealed significant differences based on activity type and sensor location. These results highlight the smart sock's sensitivity and accuracy, suggesting its potential to prevent diabetic foot ulcers. Further clinical trials are needed to evaluate its efficacy in a larger, more diverse population.
Collapse
Affiliation(s)
- Julia Billings
- School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada; (J.B.); (J.G.); (Z.G.)
| | - Julia Gee
- School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada; (J.B.); (J.G.); (Z.G.)
| | - Zinah Ghulam
- School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada; (J.B.); (J.G.); (Z.G.)
| | - Hussein A. Abdullah
- School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada; (J.B.); (J.G.); (Z.G.)
- Scientific Research Centre, Australian University, West Mishref Mubarak Al-Abdullah Al-Jaber Area, Kuwait City 13015, Kuwait
| |
Collapse
|
3
|
Wilson P, Patton D, O'Connor T, Boland F, Budri AM, Moore Z, Phelan N. Biomarkers of local inflammation at the skin's surface may predict both pressure and diabetic foot ulcers. J Wound Care 2024; 33:630-635. [PMID: 39287043 DOI: 10.12968/jowc.2024.0127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/19/2024]
Abstract
This commentary considers the similarities which exist between pressure ulcers (PUs) and diabetic foot ulcers (DFUs). It aims to describe what is known to be shared-both in theory and practice-by these wound types. It goes on to detail the literature surrounding the role of inflammation in both wound types. PUs occur following prolonged exposure to pressure or pressure in conjunction with shear, either due to impaired mobility or medical devices. As a result, inflammation occurs, causing cell damage. While DFUs are not associated with immobility, they are associated with altered mobility occurring as a result of complications of diabetes. The incidence and prevalence of both types of lesions are increased in the presence of multimorbidity. The prediction of either type of ulceration is challenging. Current risk assessment practices are reported to be ineffective at predicting when ulceration will occur. While systemic inflammation is easily measured, the presence of local or subclinical inflammation is harder to discern. In patients at risk of either DFUs or PUs, clinical signs and symptoms of inflammation may be masked, and systemic biomarkers of inflammation may not be elevated sufficiently to predict imminent damage until ulceration appears. The current literature suggests that the use of local biomarkers of inflammation at the skin's surface, namely oedema and temperature, may identify early tissue damage.
Collapse
Affiliation(s)
- Pauline Wilson
- St. James's Hospital, Dublin, Ireland
- Skin Wounds and Trauma Research Centre, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- Health Service Executive, Dublin, Ireland
| | - Declan Patton
- Skin Wounds and Trauma Research Centre, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- School of Nursing and Midwifery, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- Fakeeh College of Health Sciences, Jeddah, Saudi Arabia
- School of Nursing and Midwifery, Griffith University, Queensland, Australia
- Faculty of Science, Medicine and Health, University of Wollongong, Australia
| | - Tom O'Connor
- Skin Wounds and Trauma Research Centre, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- School of Nursing and Midwifery, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- Fakeeh College of Health Sciences, Jeddah, Saudi Arabia
- School of Nursing and Midwifery, Griffith University, Queensland, Australia
- Lida Institute, Shanghai, China
| | - Fiona Boland
- Data Science, School of Population Health, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
| | - Aglecia Mv Budri
- Skin Wounds and Trauma Research Centre, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- School of Nursing and Midwifery, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- São Paulo State University (UNESP), Faculty of Medicine, Department of Nursing, São Paulo, Brazil
| | - Zena Moore
- Skin Wounds and Trauma Research Centre, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- School of Nursing and Midwifery, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland
- Fakeeh College of Health Sciences, Jeddah, Saudi Arabia
- School of Nursing and Midwifery, Griffith University, Queensland, Australia
- Lida Institute, Shanghai, China
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia
- Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, Belgium
- University of Wales, Cardiff, UK
- National Health and Medical Research Council Centre of Research Excellence in Wiser Wound Care, Menzies Health Institute Queensland, Queensland, Australia
| | | |
Collapse
|
4
|
Thormann U, Marti S, Lensmith E, Lanz M, Herzig S, Naef R, Imanidis G. Formulation and dermal delivery of a new active pharmaceutical ingredient in an in vitro wound model for the treatment of chronic ulcers. Eur J Pharm Biopharm 2024; 202:114373. [PMID: 38906230 DOI: 10.1016/j.ejpb.2024.114373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Revised: 06/04/2024] [Accepted: 06/16/2024] [Indexed: 06/23/2024]
Abstract
The aim of this study was to investigate dermal delivery of the new active pharmaceutical ingredient (API) TOP-N53 into diabetic foot ulcer using an in vitro wound model consisting of pig ear dermis and elucidate the impact of drug formulation and wound dressing taking into consideration clinical relevance in the home care setting and possible bacterial infection. Different formulation approaches for the poorly water-soluble API including colloidal solubilization, drug micro-suspension and cosolvent addition were investigated; moreover, the effect of (micro-)viscosity of hydrogels used as primary wound dressing on delivery was assessed. Addition of Transcutol® P as cosolvent to water improved solubility and was significantly superior to all other approaches providing a sustained three-day delivery that reached therapeutic drug levels in the tissue. Solubilization in micelles or liposomes, on the contrary, did not boost delivery while micro-suspensions exhibited sedimentation on the tissue surface. Microbial contamination was responsible for considerable metabolism of the drug leading to tissue penetration of metabolites which may be relevant for therapeutic effect. Use of hydrogels under semi-occlusive conditions significantly reduced drug delivery in a viscosity-dependent fashion. Micro-rheologic analysis of the gels using diffusive wave spectroscopy confirmed the restricted diffusion of drug particles in the gel lattice which correlated with the obtained tissue delivery results. Hence, the advantages of hydrogel dressings from the applicatory characteristic point of view must be weighed against their adverse effect on drug delivery. The employed in vitro wound model was useful for the assessment of drug delivery and the development of a drug therapy concept for chronic diabetic foot ulcer. Mechanistic insights about formulation and dressing performance may be applied to drug delivery in other skin conditions such as digital ulcer.
Collapse
Affiliation(s)
- Ursula Thormann
- School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland
| | - Selina Marti
- School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland
| | - Elizabeth Lensmith
- School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland
| | - Michael Lanz
- School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland
| | - Susanne Herzig
- School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland
| | - Reto Naef
- Topadur Pharma AG, Schlieren, Switzerland
| | - Georgios Imanidis
- School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland.
| |
Collapse
|
5
|
Liew H, Tang W, Plassmann P, Machin G, Simpson R, Edmonds ME, Petrova NL. Infrared Thermography Shows That a Temperature Difference of 2.2°C (4°F) or Greater Between Corresponding Sites of Neuropathic Feet Does Not Always Lead to a Diabetic Foot Ulcer. J Diabetes Sci Technol 2024:19322968241249970. [PMID: 38708580 PMCID: PMC11571440 DOI: 10.1177/19322968241249970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/07/2024]
Abstract
BACKGROUND There is emerging interest in the application of foot temperature monitoring as means of diabetic foot ulcer (DFU) prevention. However, the variability in temperature readings of neuropathic feet remains unknown. The aim of this study was to analyze the long-term consistency of foot thermograms of diabetic feet at the risk of DFU. METHODS A post-hoc analysis of thermal images of 15 participants who remained ulcer-free during a 12-month follow-up were unblinded at the end of the trial. Skin foot temperatures of 12 plantar, 15 dorsal, 3 lateral, and 3 medial regions of interests (ROIs) were derived on monthly thermograms. The temperature differences (∆Ts) of corresponding ROIs of both feet were calculated. RESULTS Over the 12-month study period, out of the total 2026 plantar data points, 20.3% ROIs were rated as abnormal (absolute ∆T ≥ 2.2°C). There was a significant between-visit variability in the proportion of plantar ROIs with ∆T ≥ 2.2°C (range 7.6%-30.8%, chi-square test, P = .001). The proportion of patients presenting with hotspots (ROIs with ∆T ≥ 2.2°C), abnormal plantar foot temperature (mean ∆T of 12 plantar ROIs ≥ 2.2°C), and abnormal whole foot temperature (mean ∆T of 33 ROIs ≥ 2.2°C) varied between visits and showed no pattern (P > .05 for all comparisons). This variability was not related to the season of assessment. CONCLUSIONS Despite the high rate of hotspots on monthly thermograms, all feet remained intact. This study underscores a significant between-visit inconsistency in thermal images of neuropathic feet which should be considered when planning DFU-prevention programs for self-testing and behavior modification.
Collapse
Affiliation(s)
- Huiling Liew
- Diabetic Foot Clinic, King’s College Hospital NHS Foundation Trust, London, UK
- Department of Endocrinology, Tan Tock Seng Hospital, Singapore
| | - Wegin Tang
- Diabetic Foot Clinic, King’s College Hospital NHS Foundation Trust, London, UK
| | | | - Graham Machin
- Temperature and Humidity Group, National Physical Laboratory, London, UK
| | - Robert Simpson
- Temperature and Humidity Group, National Physical Laboratory, London, UK
| | - Michael E. Edmonds
- Diabetic Foot Clinic, King’s College Hospital NHS Foundation Trust, London, UK
- Diabetes and Obesity, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
| | - Nina L. Petrova
- Diabetic Foot Clinic, King’s College Hospital NHS Foundation Trust, London, UK
- Diabetes and Obesity, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
| |
Collapse
|
6
|
Kress S, Anderten H, Borck A, Freckmann G, Heinemann L, Holzmüller U, Kulzer B, Portele A, Schnell O, Varlemann H, Zemmrich C, Lobmann R. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score. J Diabetes Sci Technol 2021; 15:816-826. [PMID: 32522035 PMCID: PMC8258539 DOI: 10.1177/1932296820922592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Preulcerous risk situations in patients with diabetes are often undiagnosed and care administered too late. Even with regular medical check-ups and status documentation, foot examinations have not been given enough attention. Diagnosing an individual patients' risk of developing diabetic foot ulcers may increase vigilance for diabetic foot syndrome (DFS), and the appropriate prevention measures matching the risk involved may prevent the emergence of diabetic ulcers. The classical DFS risk factors are well established and have been extensively covered in the literature; however, there is a lack of efficient screening tools that could be used for a rapid assessment of diabetic foot ulcer risk. METHODS A methodical literature search was conducted to assess relevant publications for the preparation of a simple risk score for amputation related to diabetic foot ulcer. We then analyzed the risk factors for predictive value as odds ratios in foot ulcers and/or amputation. We used the available data to deduce a mean value to reflect the authors' consensus. RESULTS In view of the current literature on the matter, we have developed a semi-quantitative scoring system using just a few items to allow rapid and visual risk assessment for diabetic foot ulcers alongside recommendations for prevention and a sensible follow-up strategy to match the risk. CONCLUSION This relatively simple score enables rapid risk classification for patients that can ease the way for both physicians and patients in gaining an insight into individual risk situations. The score provides more effective preventative measures for high-risk patients against future complications.
Collapse
Affiliation(s)
- Stephan Kress
- Vinzentinus-Krankenhaus, Landau, Germany
- Stephan Kress, MD, Diabeteszentrum, Vinzentius-Krankenhaus, Cornichonstrasse 4, 76829 Landau, Germany.
| | - Helmut Anderten
- Gemeinschaftspraxis Anderten-Krok & Partner, Hildesheim, Germany
| | - Anja Borck
- Sanofi-Aventis Deutschland GmbH, Berlin, Germany
| | - Guido Freckmann
- Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Germany
| | | | - Ulrike Holzmüller
- Klinik für Endokrinologie und Nephrologie der Universität Leipzig, Germany
| | - Bernd Kulzer
- Forschungsinstitut der Diabetes Akademie Bad Mergentheim (FIDAM), Germany
| | | | | | | | - Claudia Zemmrich
- Praxis für Cardiovascular- und Ultraschalldiagnostik, Herz-Kreislauf-Erkrankungen und Psychotherapie, Berlin, Germany
| | - Ralf Lobmann
- Klinik für Endokrinologie, Diabetologie und Geriatrie, Stuttgart, Germany
| |
Collapse
|
7
|
Jarocki C, Schmidt BM, Holmes CM. Vehicle ergonomics contributing to a diabetic foot ulcer. Clin Diabetes Endocrinol 2019; 5:14. [PMID: 31720006 PMCID: PMC6839194 DOI: 10.1186/s40842-019-0089-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Accepted: 10/25/2019] [Indexed: 11/25/2022] Open
Abstract
Background Diabetes mellitus continues to be a rising concern in the United States. It affects an estimated 9.4% of the population and approximately 1.5 million Americans are diagnosed annually. Approximately 85% of diabetic foot ulcers are associated with diabetic peripheral neuropathy and an infected diabetic foot ulcer is often the first sign of diabetes. There are countless studies within the literature that investigate how insensate feet and the manifestation of a foot ulcer further decrease quality of life and increase risk for mortality. Literature focuses on gait and kinematics that contribute to the formation of a diabetic foot ulcer. While pressure and shear forces are etiologic factors that may lead to the formation of diabetic foot ulcers, the position of the foot while driving an automobile has been ignored as a possible risk factor. Case presentation The clinical case will describe the events of healing a neuropathic diabetic foot ulcer beyond the standard of care treatment plan. It is one of the first case reports to describe vehicle ergonomics as an etiologic factor contributing to a diabetic foot ulcer. Once the patient becomes aware of the unnecessary source of pressure, education and care is provided to manage this likely source of daily pressure to the neuropathic foot. Conclusion The article emphasizes the importance of a complete assessment, including nontraditional factors, which may lead to diabetic complications.
Collapse
Affiliation(s)
- Christine Jarocki
- Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Hospital and Health System, Domino's Farms Lobby G, Suite 1500, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106 USA
| | - Brian M Schmidt
- Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Hospital and Health System, Domino's Farms Lobby G, Suite 1500, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106 USA
| | - Crystal Murray Holmes
- Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Hospital and Health System, Domino's Farms Lobby G, Suite 1500, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106 USA
| |
Collapse
|